EMAS Interactive Roundtable
Register now for the Next EMAS Interactive Roundtable
Session structure
- Interactive learning and practice exchange with international experts will be structured according to the following format:
- Short presentations by the international experts.
- Interactive debate in three steps:
- 1) Q & A between the expert speakers and a discussion panel.
2) Open dialogue with all attendees.
3) Assessment with multiple choice questions using an internet platform.
Meeting details
The event will be a virtual meeting and will be accessible from this website
– Live Interaction with the speakers and Q&A
– Can be viewed Worldwide with no delay
– Event start always at 2.00 p.m. CET Paris time = 8.00 a.m. EST New York = 8.00 p.m. Singapore time
– Free registration
Registration
Click on “registration” to register and create an account. You will receive an email with a link to click on to confirm your account. Afterwards, you can subscribe to individual or all Roundtable and access them afterwards.
Login with your credential
Access to all Interactive Roundtable.
Interactive Roundtable replay
All registered users can replay the Roundtable discussions and its video and access the certificate of attendance.
Psychological associations of menopause and their management
18 November 2021
2.00 – 3.00 p.m. CET (Paris)
Chair: Prof. Petra Stute, Switzerland
Co-Chair: Dr. Josyan Madi-Skaff, Lebanon
Topic 1: Mental Health in Woman
Dr. Areti Spyropoulou, Greece
Topic 2: Treatment of Mental Health Problems in Menopause
Univ. Prof. Donna Stewart, Canada
Topic 3: The role of MHT
Prof. Petra Stute, Switzerland
Discussion with mentees and delegates
Dr. Anastasia Armeni, Greece
Dr. Ioannis Boutas, Greece
followed by an Elearning Education + Certificate
The importance of an individualised approach to the clinical management of climacteric symptoms
19 January 2022
2.00 – 3.00 p.m. CET (Paris)
Chair: Prof. Alfred Mueck, Germany
Co-Chair: Prof. Angelica Linden Hirschberg, Sweden
Topic 1: Individualized MHT to optimise metabolic and vascular effects
Prof. Alfred Mueck, Germany
Topic 2: MHT in the context of breast cancer: stratifying the risk
Dr. Antonina Smetnik, Russia
Topic 3: MHT in women at risk or after gynecological cancer
Prof. Angelica Linden Hirschberg
Topic 4: MHT and Cardiovascular Disease
Dr. Nicolas Mendoza, Spain
Discussion with mentees and delegates
Dr. Maria Charmanta, Greece
Dr. Katerina Stefanaki, Greece
followed by an Elearning Education + Certificate
Benefits and risk of MHT: the 2021 perspective
8 December 2021
2.00 – 3.00 p.m. CET (Paris)
Chair: Dr. Antonina Smetnik, Russia
Co-Chair: Prof. Marco Gambacciani, Italy
Topic 1: MHT and Postmenopausal Osteoporosis
Prof. Marco Gambacciani, Italy
Topic 2: MHT and Breast cancer
Dr. Antonina Smetnik, Russia
Topic 3: MHT and Diabetes Mellitus
Assist. Prof. Stavroula A. Paschou, Greece
Discussion with mentees and delegates
Dr. Nektaria Papanikola, Greece
Dr. Maria Stamou, USA
followed by an Elearning Education + Certificate
Calculating cardiovascular risk in women with indications for menopausal hormone therapy
23 February 2022
2.00 – 3.00 p.m. CET (Paris)
Chair: Prof. Irene Lambrinoudaki, Greece
Topic 1: Long-term consequences of menopause
Dr. Stephanie S. Faubion, USA
Topic 2: Customising MHT according to CVD risk: case presentations
Prof. John Stevenson, UK
Topic 3: Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions
Dr. Angela Maas, The Netherlands
Discussion with mentees and delegates
Dr. Morgan Orly, USA
Dr. Ipek Betul Ozcivit, Turkey
followed by an Elearning Education + Certificate